
|Articles|January 29, 2016
Frequently Asked Questions About Pharmacy DIR Fees
Government affairs strategist Ron Lanton III, Esq, interviews Susan Pilch, vice president of policy and regulatory affairs for the National Community Pharmacists Association, about direct and indirect remuneration fees.
Advertisement
Government affairs strategist Ron Lanton III, Esq, interviews Susan Pilch, vice president of policy and regulatory affairs for the National Community Pharmacists Association, about direct and indirect remuneration fees.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Toothpaste Tablets Are Gaining Popularity—Here’s Where Pharmacists Fit In
2
Beyond Injections: Orforglipron and the Future of Oral GLP-1 Receptor Agonist Therapy
3
Former FDA Chief Scientist Jesse Goodman Breaks Down the Implications of Pediatric Vaccine Guideline Changes
4
Federal Health Officials Scale Back Number of Recommended Vaccines for Children
5













































































































































































































